Breast Neoplasm Malignant Primary
Conditions
Brief summary
Breast cancer surgery is known to cause severe acute postoperative pain, which can persist for a long time. The investigators administered nefopam preventively to patients undergoing total mastectomy or modified radical mastectomy with axillary lymph node dissection or sentinel lymph node biopsy, and evaluated its efficacy on acute and chronic postoperative pain.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Total mastectomy * Modified radical mastectomy * Nipple-sparing mastectomy * American Society of Anesthesiologists physical status I or II * Postoperative use of intravenous patient-controlled analgesia
Exclusion criteria
* Chronic analgesia medication * Pregnancy * Lactating women * Previous operation history due to breast cancer * Cooperation with other surgery * Contraindication of nefopam
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of cumulative analgesia volume infused via intravenous patient-controlled analgesia device | At postoperative 4 hour, 24 hour, 48 hour, 72 hour, 10 day, and 3 month |
Secondary
| Measure | Time frame |
|---|---|
| Change of numerical rating scale for postoperative pain | At postoperative 4 hour, 24 hour, 48 hour, 72 hour, 10 day, and 3 month |
Countries
South Korea